261 related articles for article (PubMed ID: 31216323)
1. Industrial perceptions of medicines regulatory harmonization in the East African Community.
Dansie LS; Odoch WD; Årdal C
PLoS One; 2019; 14(6):e0218617. PubMed ID: 31216323
[TBL] [Abstract][Full Text] [Related]
2. What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements.
Miletic N; Adam S; Acquah J; Aziz Z; Joos A; Mwangi JM
Front Med (Lausanne); 2023; 10():1207954. PubMed ID: 37731723
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward.
Ngum N; Mashingia J; Ndomondo-Sigonda M; Walker S; Salek S
Front Pharmacol; 2022; 13():891506. PubMed ID: 35865962
[No Abstract] [Full Text] [Related]
4. Regulatory performance of the East African Community joint assessment procedure: The way forward for regulatory systems strengthening.
Mashingia J; Ngum N; Ndomondo-Sigonda M; Kermad A; Bujar M; Salek S; Walker S
Regul Toxicol Pharmacol; 2023 May; 140():105383. PubMed ID: 36933643
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement.
Ngum N; Mashingia J; Ndomondo-Sigonda M; Walker S; Salek S
Front Pharmacol; 2022; 13():1031289. PubMed ID: 36408267
[No Abstract] [Full Text] [Related]
6. Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.
Ndomondo-Sigonda M; Miot J; Naidoo S; Masota NE; Ng'andu B; Ngum N; Kaale E
BMC Public Health; 2021 Jan; 21(1):187. PubMed ID: 33478421
[TBL] [Abstract][Full Text] [Related]
7. Impact of regulatory requirements on medicine registration in African countries - perceptions and experiences of pharmaceutical companies in South Africa.
Narsai K; Williams A; Mantel-Teeuwisse AK
South Med Rev; 2012 Jul; 5(1):31-7. PubMed ID: 23093897
[TBL] [Abstract][Full Text] [Related]
8. Best practices in the African Medicines Regulatory Harmonization initiative: Perspectives of regulators and medicines manufacturers.
Ndomondo-Sigonda M; Azatyan S; Doerr P; Agaba C; Harper KN
PLOS Glob Public Health; 2023; 3(4):e0001651. PubMed ID: 37186241
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry.
Owusu-Asante M; Darko DM; Walker S; Salek S
Front Pharmacol; 2023; 14():1184108. PubMed ID: 37229251
[No Abstract] [Full Text] [Related]
10. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
[TBL] [Abstract][Full Text] [Related]
11. Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
Ahonkhai V; Martins SF; Portet A; Lumpkin M; Hartman D
PLoS One; 2016; 11(11):e0166515. PubMed ID: 27851831
[TBL] [Abstract][Full Text] [Related]
12. Regional regulatory harmonisation initiatives: Their potential contribution to the newly established African Medicines Agency.
Ngum N; Ndomondo-Sigonda M; Walker S; Salek S
Regul Toxicol Pharmacol; 2023 Dec; 145():105497. PubMed ID: 37778434
[TBL] [Abstract][Full Text] [Related]
13. Improving access to quality medicines in East Africa: An independent perspective on the East African Community Medicines Regulatory Harmonization initiative.
Giaquinto AR; Grignolo A; Liberti L; Lim JCW; Salmonson T; Sauer F; Ukwu H
PLoS Med; 2020 Aug; 17(8):e1003092. PubMed ID: 32785224
[TBL] [Abstract][Full Text] [Related]
14. Harmonization, regulation, and trade: interactions in the pharmaceutical field.
Timmermans K
Int J Health Serv; 2004; 34(4):651-61. PubMed ID: 15560428
[TBL] [Abstract][Full Text] [Related]
15. Regulation of medical diagnostics and medical devices in the East African community partner states.
Rugera SP; McNerney R; Poon AK; Akimana G; Mariki RF; Kajumbula H; Kamau E; Mpawenimana S; Said SY; Toroitich A; Ronoh W; Sollis KA; Sonoiya S; Peeling RW
BMC Health Serv Res; 2014 Oct; 14():524. PubMed ID: 25366990
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries.
Owusu-Asante M; Darko DM; Walker S; Salek S
Front Pharmacol; 2022; 13():1069345. PubMed ID: 36506579
[No Abstract] [Full Text] [Related]
17. Coming together to improve access to medicines: The genesis of the East African Community's Medicines Regulatory Harmonization initiative.
Sillo H; Ambali A; Azatyan S; Chamdimba C; Kaale E; Kabatende J; Lumpkin M; Mashingia JH; Mukanga D; Nyabenda B; Sematiko G; Sigonda M; Simai B; Siyoi F; Sonoiya S; Ward M; Ahonkhai V
PLoS Med; 2020 Aug; 17(8):e1003133. PubMed ID: 32785273
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward.
Sithole T; Mahlangu G; Walker S; Salek S
Front Med (Lausanne); 2022; 9():898725. PubMed ID: 35547215
[TBL] [Abstract][Full Text] [Related]
19. National medicines regulatory authorities financial sustainability in the East African Community.
Ndomondo-Sigonda M; Miot J; Naidoo S; Ng'andu B; Ngum N; Masota NE; Kaale E
PLoS One; 2020; 15(7):e0236332. PubMed ID: 32702048
[TBL] [Abstract][Full Text] [Related]
20. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
